SKIN financial statements and SEC filings

SKIN annual income statement

Fiscal period endRevenueOperating incomeNet incomeSEC filing
2025-12-31$300.79M-$20.80M-$9.52M10-K
2024-12-31$334.29M-$67.77M-$29.10M10-K
2023-12-31$397.99M-$130.92M-$100.12M10-K
2022-12-31$365.88M-$25.84M$44.22M10-K
2021-12-31$260.09M-$39.93M-$378.76M10-K
2020-12-31$119.09M-$17.18M-$29.18M10-K

SKIN annual balance sheet

Fiscal period endAssetsLiabilitiesEquitySEC filing
2025-12-31$499.80M$438.75M$61.06M10-Q
2024-12-31$685.68M$633.88M$51.80M10-K
2023-12-31$929.11M$869.72M$59.39M10-K
2022-12-31$1.00B$836.03M$167.05M10-K
2021-12-31$1.22B$916.51M$302.30M10-K
2020-12-31$222.84M$252.79M-$29.96M10-K

SKIN annual cash flow

Fiscal period endOperating cash flowCapital expenditureFinancing cash flowSEC filing
2025-12-31$37.48M-$303.00K-$174.93M10-K
2024-12-31$16.13M-$756.00K-$158.34M10-K
2023-12-31$21.75M-$3.83M-$37.45M10-K
2022-12-31-$106.60M-$10.85M-$205.24M10-K
2021-12-31-$28.36M-$11.20M$959.03M10-K
2020-12-31-$12.44M-$3.50M$18.27M10-K